The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 162.00
Ask: 162.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.309%)
Open: 163.00
High: 164.50
Low: 162.00
Prev. Close: 162.50
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

9 Oct 2015 15:04

RNS Number : 8531B
Clarke(T.) PLC
09 October 2015
 

T.CLARKE PLC(the "Company")

SAVINGS RELATED SHARE OPTION SCHEME - GRANT OF OPTIONS

 

On 9th October 2015, the Directors of the Company were granted options over ordinary shares of 10p each in the capital of the Company ("Shares") under the T.Clarke plc Savings Related Share Option Scheme ("the Scheme"). 

Details of the directors and the number of shares over which options were granted to them under the Scheme are as follows:

Director

Number of share options

Exercise price of options

Mark Lawrence

10,322

69.75p /share

Mike Crowder

10,322

69.75p /share

Martin Walton

10,322

69.75p /share

The above represents the maximum number of options available to the directors under the rules of the Scheme. No consideration was paid for the grant of the options.

The Scheme was formally launched for 2015 on 9th September 2015 and was made available to all eligible employees. The options have an exercise price of 69.75 pence per share which represents a discount of 10% to the market price at close on 8th September 2015, being the day preceding the Scheme launch.

Options may normally be exercised during the six months following the Maturity Date at the end of the three-year savings period. The Maturity Date is 30 November 2018. A total of 1,744,284 shares are under option for the Scheme.

Following the grant of the options under the Scheme the Executive Directors hold the following beneficial interests in the issued share capital of the Company:

Director

Beneficial Interest in the Shares of the Company

% of the Issued Share Capital of the Company

Number of Conditional Share Awards Held Under the LTIP Scheme

Total No. Options Under the LTIP Scheme

Total Number of Shares Under SAYE Scheme Option

Mark Lawrence

26,750

0.05%

290,000

59,000

24,845

Mike Crowder

18,750

0.03%

290,000

59,000

24,845

Martin Walton

16,750

0.02%

290,000

59,000

24,845

Danny Robson

1,451,906

3.47%

90,000

Nil

Nil

For further information contact:

TClarke plc

Mark Lawrence, Group Chief Executive

Martin Walton, Finance DirectorAlexandra Dent, Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

 

N+1 Singer (Financial Adviser and Broker)

Sandy Fraser, Partner

Tel: 020 7496 3000

www.n1singer.com

 

Broker Profile

Simon Courtenay

Harry Rippon

Tel: 020 7448 3244

www.broker-profile.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMLBITMBMMBMA
Date   Source Headline
4th Jan 202312:09 pmRNSBlock listing Interim Review
24th Nov 20227:00 amRNSTrading Statement
1st Nov 20225:13 pmRNSESOT Share Purchase
25th Oct 20222:14 pmRNSESOT Share Purchase
18th Jul 20227:00 amRNSInvestor Presentation
14th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:12 pmRNSBlock listing 6 Monthly Return
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.